Autonomous Airborne Pathogen Containment System

Publication ID: 24-11857465_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Autonomous Airborne Pathogen Containment System,” Published Technical Disclosure No. 24-11857465_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857465_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,465.

Summary of the Inventive Concept

A next-generation air isolation system that integrates AI, real-time pathogen detection, and adaptive ventilation to autonomously contain and eliminate airborne pathogens, revolutionizing pandemic response and patient care.

Background and Problem Solved

The original portable collapsible air isolation apparatus, while effective, has limitations in terms of its manual operation, limited adaptability to evolving pathogens, and lack of real-time detection capabilities. The new inventive concept addresses these limitations by introducing autonomous, AI-driven, and real-time pathogen detection and elimination capabilities, enabling more effective and efficient pandemic response.

Detailed Description of the Inventive Concept

The Autonomous Airborne Pathogen Containment System consists of a modular, self-sustaining air isolation chamber, an integrated AI-powered ventilation unit, and a wearable, real-time pathogen detection module. The system autonomously adapts to evolving airborne pathogens through machine learning algorithms and dynamically adjusts ventilation and filtration parameters to optimize pathogen containment. Additionally, the system features a hybrid, bio-inspired air isolation apparatus with a 3D-printed, lattice-structured enclosure, a biomimetic, adaptive ventilation system, and an integrated CRISPR-Cas13-based pathogen detection and elimination module. The system can be decentralized through a blockchain-based air isolation network, enabling community-driven innovation and global pandemic response.

Novelty and Inventive Step

The new claims introduce a paradigm shift in air isolation technology by integrating AI, real-time pathogen detection, and adaptive ventilation, enabling autonomous pathogen containment and elimination. The inventive step lies in the combination of these features, which surpasses the original patent's capabilities and provides a more effective and efficient solution for pandemic response and patient care.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the chamber design, ventilation systems, and pathogen detection modules. For example, the chamber could be designed for use in different environments, such as hospitals, homes, or public spaces. The ventilation system could be adapted for use with different types of pathogens, and the pathogen detection module could be integrated with other diagnostic tools.

Potential Commercial Applications and Market

The Autonomous Airborne Pathogen Containment System has significant commercial potential in the healthcare, biotechnology, and pandemic response industries. The system could be marketed as a standalone product or integrated into existing healthcare infrastructure, providing a new standard for airborne pathogen containment and patient care.

CPC Classifications

SectionClassGroup
A A61 A61G10/005
A A61 A61G10/023
A A61 A61M5/1415

Field of Art

Medical isolation and containment technologies, specifically portable patient isolation systems with air filtration and pathogen management, requiring expertise in medical engineering, biomedical design, and infectious disease control technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degrees, experience in medical isolation systems, knowledge of air filtration technologies, understanding of modular medical equipment design, and familiarity with emerging pandemic response technologies

Obviousness Rationale

A PHOSITA would recognize that the PTD's autonomous air isolation system represents a predictable technological evolution of the source patent's collapsible isolation apparatus, leveraging known techniques in AI, sensor technologies, and adaptive filtration to enhance pathogen containment. The core structural elements of a portable, collapsible chamber remain consistent, with the primary innovation being the integration of intelligent monitoring and adaptive response systems. These technological extensions would be considered obvious improvements within the standard problem-solving approach of medical device engineering.

Obvious Combinations & Variations

Source Patent Element
Collapsible frame with rigid/soft panel elements for patient isolation
PTD Variation
3D-printed lattice-structured enclosure with modular, adaptive design
Obviousness Reasoning
Predictable design variation using known additive manufacturing techniques to improve structural flexibility and customization, representing a routine engineering optimization
Source Patent Element
Air filter coupled to motor for pathogen management
PTD Variation
AI-powered ventilation unit with dynamic filtration parameter adjustment
Obviousness Reasoning
Known application of machine learning to existing filtration technologies, representing an incremental improvement in adaptive system control
Source Patent Element
Access port for medical operator interaction
PTD Variation
Integrated CRISPR-Cas13-based pathogen detection and elimination module
Obviousness Reasoning
Logical extension of existing medical intervention technologies, utilizing emerging molecular detection techniques within established isolation system frameworks
Source Patent Element
Translucent surfaces for patient visibility
PTD Variation
Real-time multimodal sensor array for comprehensive environmental monitoring
Obviousness Reasoning
Predictable technological progression from visual monitoring to comprehensive sensor-based environmental tracking, representing a standard engineering approach to system enhancement
Source Patent Element
Portable collapsible isolation apparatus
PTD Variation
Decentralized, blockchain-based air isolation network
Obviousness Reasoning
Obvious technological convergence of existing isolation technologies with distributed computing paradigms, representing a standard approach to system scalability and information sharing
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857465 and the published technical disclosure, a person having ordinary skill in the art would find the claimed autonomous air isolation system variations obvious and anticipated, as the disclosed innovations represent predictable technological extensions employing known techniques in medical device design, sensor integration, and adaptive system control, thereby rendering subsequent claims of novelty invalid under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,465
TitlePortable collapsible air isolation apparatus